ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,019Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 617

$569K Total Retail Price of All Prescriptions

Rank: 59 out of 617

568 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 568 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 568 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 15,231 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 1,047 1,007 1 1
SIMVASTATIN 839 808 2 2
METOPROLOL SUCCINATE 587 565 3 12
OMEPRAZOLE 499 474 4 3
FUROSEMIDE 486 486 5 4
WARFARIN SODIUM 482 470 6 7
LISINOPRIL 462 445 7 5
METOPROLOL TARTRATE 392 388 8 11
AMLODIPINE BESYLATE 384 373 9 6
METFORMIN HCL 367 354 10 9
SERTRALINE HCL 357 346 11 20
PRAVASTATIN SODIUM 316 303 12 21
ATORVASTATIN CALCIUM 282 268 13 14
ALLOPURINOL 272 254 14 27
HYDROCODONE-ACETAMINOPHEN 267 259 S3 15 8
POTASSIUM CHLORIDE 266 266 16 10
ATENOLOL 258 245 17 17
RANITIDINE HCL 255 251 18 40
GABAPENTIN 214 206 19 16
HYDROCHLOROTHIAZIDE 189 184 20 13
TAMSULOSIN HCL 187 187 21 26
CRESTOR 181 178 22 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 180 180 23 29
LOSARTAN POTASSIUM 175 170 24 22
CITALOPRAM HBR 173 146 25 18
TRAMADOL HCL 168 159 26 15
POLYETHYLENE GLYCOL 3350 164 140 27 32
FLUTICASONE PROPIONATE 148 139 28 36
GLIMEPIRIDE 145 142 29 33
DIGOXIN 131 131 30 48
ALENDRONATE SODIUM 127 114 31 25
CARVEDILOL 120 109 32 19
DONEPEZIL HCL 115 115 33 30
BENAZEPRIL HCL 110 110 34 44
AMITRIPTYLINE HCL 106 94 R 35 56
LIPITOR 101 95 36 118
EVISTA 94 94 37 119
ZOLPIDEM TARTRATE 92 91 38 23
DILTIAZEM 24HR ER 92 91 38 162
MIRTAZAPINE 92 69 38 50
FINASTERIDE 89 89 41 104
CHLORTHALIDONE 88 85 42 123
ZOSTAVAX 85 80 43 99
NEXIUM 83 71 44 43
DOXAZOSIN MESYLATE 83 83 44 79
ADVAIR DISKUS 79 74 46 38
FENOFIBRATE 78 67 47 58
ZETIA 77 77 48 77
PREDNISONE 72 70 49 31
LANTUS 72 72 49 39
LOVASTATIN 72 60 49 57
PROPRANOLOL HCL 72 64 49 109
TRAZODONE HCL 70 58 53 51
DIOVAN HCT 69 69 54 97
VERAPAMIL ER 66 66 55 90
ISOSORBIDE MONONITRATE ER 66 63 55 52
LOSARTAN-HYDROCHLOROTHIAZIDE 64 64 57 46
DIOVAN 64 56 57 41
BENAZEPRIL-HYDROCHLOROTHIAZIDE 64 57 57 168
ENALAPRIL MALEATE 61 61 60 34
GLYBURIDE 61 54 R 60 84
LYRICA 59 47 62 92
MECLIZINE HCL 58 58 63 150
TRIAMTERENE-HCTZ 57 35 64 47
VENLAFAXINE HCL ER 57 39 64 76
AZITHROMYCIN 55 54 66 70
NOVOLOG 54 54 67 137
SPIRONOLACTONE 54 54 67 42
SYMBICORT 53 53 69 141
MELOXICAM 53 51 69 24
FENTANYL 52 43 S2 71 45
FLUOXETINE HCL 52 52 71 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 23, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.